Specific immunotherapy in Albanian patients with anaphylaxis to hymenoptera venoms

BMC Family Practice

David A Groneberg¹  Christian Peiser¹  Axel Fischer¹  Q Thai Dinh¹  Etleva Qirko²  Alfred Priftanji²  Ervin Mingomataj¹ 

[1] Division of Allergy Research, Dept. of Pediatric Pneumology and Immunology, Charité School of Medicine, Humboldt-University, D-13353 Berlin, Germany;Dept. of Allergy, Mother Theresa School of Medicine, University of Tirana, Tirana, Albania

关键词: anaphylactic reactions;    Rush-SIT;    Rush;    hymenoptera;   

Others  :  856887
DOI  :  10.1186/1471-5945-2-11

 received in 2002-04-25, accepted in 2002-08-30,  发布年份 2002

【 摘 要 】

Background

Severe allergic reactions during rush-specific immunotherapy (Rush-SIT) may occur in the treatment of hymenoptera sting allergy. The objective of the present study was to examine the characteristics of allergic reactions during Rush-SIT in a cohort of patients with allergy towards hymenoptera venom in the mediterranean population of Albania.

Methods

A retrospective study was performed using the clinical reports of 37 patients with venom of bee (apinae), wasp (vespidae, subfamily vespinae) or paperwasp (vespidae, subfamily polistinae) allergy treated with Rush-SIT between 1987 and 1996. After hymenoptera sting allergy diagnosis according to anamnesis and intracutaneous tests the patient were treated with Rush-SIT. The protocol lasted 3 – 4 d with an increase in the concentration from 0.01 μg/ml to 100 μg/ml. Anaphylactic reactions were classified according to the Mueller-classification.

Results

The frequency of reactions during Rush-SIT for bee-venom was 4.7% and for wasp-venom was 1.5% (p < 0.01). The mean frequency of reactions of Mueller grade II for the bee-venom Rush-SIT patients during the first 4 d (= 26 injections) was 0.73 and for the wasp-venom Rush-SIT patients 0.15. No patient experienced a third-degree reaction. 94.6% of the patient supported an end dose of 100 μg.

Conclusions

Rush-SIT is a reliable method for the treatment of anaphylactic reactions to hymenoptera venom even in less developed countries. Bee-venom Rush-SIT was found to cause higher numbers allergic reactions than wasp or paperwasp Rush-SIT.

【 授权许可】

   
2002 Mingomataj et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.

【 图 表 】

【 参考文献 】

• [1]Mosbech H: Death caused by wasp and bee stings in Denmark 1960–1980. Allergy 1983, 38:195-200.
• [2]Barnard JH: Studies of 400 Hymenoptera sting deaths in the United States. J Allergy Clin Immunol 1973, 52:259-264.
• [3]Georgitis J, Reisman R: Venom skin tests in insect-allergic and insect-nonallergic populations. J Allergy Clin Immunol 1985, 76:803-807.
• [4]Müller U, Mosbech H, Blaauw P, Dreborg S, Malling H, Przybilla B, Urbanek R, Pastorello E, Blanca M, Bosquet J, Jarisch R, Youlten L: Emergency treatment of allergic reactions to hymenoptera stings. Clin Exp Allergy 1991, 21:281-288.
• [5]Valentine M, Schuberth K, Sobotka A, Graft D, Kwiterovich K, Szklo M, Lichtenstein L: The value of immunotherapy with venom in children with allergy to insect stings. N Engl J Med 1990, 323:1601-1603.
• [6]Golden DB, Marsh DG, Kagey-Sobotka A, Freidhoff L, Szklo M, Valentine MD, Lichtenstein LM: Epidemiology of insect venom sensitivity. JAMA 1989, 262:240-244.
• [7]McGain F, Harrison J, Winkel KD: Wasp sting mortality in Australia. Med J Aust 2000, 173:198-200.
• [8]Molina C: Acquisitions récentes sur l'allergie aux hyménoptères. Immunol médicale 1985, 10:67-71.
• [9]Reisman R: Insect stings. N Engl J Med 1994, 331:523-527.
• [10]Rueff F, Reissig J, Przybilla B: Side effects of rush hyposensitization with hymenoptera venoms. Allergo J 1997, 6:59-64.
• [11]Mueller HL: Insect allergy. Pediatr Clin North Am 1959, 6:917-952.
• [12]Cohen SG: The pharaoh and the wasp. Allergy Proc 1989, 10:149-151.
• [13]Hunt KJ, Valentine MD, Sobotka AK, Benton AW, Amodio FJ, Lichtenstein LM: A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med 1978, 299:157-161.
• [14]Golden DB, Schwartz HJ: Guidelines for venom immunotherapy. J Allergy Clin Immunol 1986, 77:727-728.
• [15]Lockey RF, Turkeltaub PC, Olive ES, Hubbard JM, Baird-Warren IA, Bukantz SC: The Hymenoptera venom study. III: Safety of venom immunotherapy. J Allergy Clin Immunol 1990, 86:775-780.
• [16]Mosbech H, Malling HJ, Biering I, Bowadt H, Soborg M, Weeke B, Lowenstein H: Immunotherapy with yellow jacket venom. A comparative study including three different extracts, one adsorbed to aluminium hydroxide and two unmodified. Allergy 1986, 41:95-103.
• [17]Bousquet J, Muller UR, Dreborg S, Jarisch R, Malling HJ, Mosbech H, Urbanek R, Youlten L: Immunotherapy with Hymenoptera venoms. Position paper of the Working Group on Immunotherapy of the European Academy of Allergy and Clinical Immunology. Allergy 1987, 42:401-413.
• [18]Reisman RE, Livingston A: Late-onset allergic reactions, including serum sickness, after insect stings. J Allergy Clin Immunol 1989, 84:331-337.
• [19]Reisman RE, Livingston A: Venom immunotherapy: 10 years of experience with administration of single venoms and 50 micrograms maintenance doses. J Allergy Clin Immunol 1992, 89:1189-1195.
• [20]Reisman RE: Duration of venom immunotherapy: relationship to the severity of symptoms of initial insect sting anaphylaxis. J Allergy Clin Immunol 1993, 92:831-836.
• [21]Rueff F, Przybilla B, Muller U, Mosbech H: The sting challenge test in Hymenoptera venom allergy. Position paper of the Subcommittee on Insect Venom Allergy of the European Academy of Allergology and Clinical Immunology. Allergy 1996, 51:216-225.
• [22]Laurent J, Smiejan JM, Bloch-Morot E, Herman D: Safety of Hymenoptera venom rush immunotherapy. Allergy 1997, 52:94-96.
• [23]Hoffman DR, Wood CL: Allergens in Hymenoptera venom XI. Isolation of protein allergens from Vespula maculifrons (yellow jacket) venom. J Allergy Clin Immunol 1984, 74:93-103.
• [24]Valentine MD: Insect venom allergy: diagnosis and treatment. J Allergy Clin Immunol 1984, 73:299-304.
• [25]Berchtold E, Maibach R, Muller U: Reduction of side effects from rush-immunotherapy with honey bee venom by pretreatment with terfenadine. Clin Exp Allergy 1992, 22:59-65.
• [26]Westall GP, Thien FC, Czarny D, O'Hehir RE, Douglas JA: Adverse events associated with rush hymenoptera venom immunotherapy. Med J Aust 2001, 174:227-230.